Review | Open Access

Physical exercise for obesity and T2DM mitigation in Polycystic Ovary Syndrome: the role of adipose tissue

Views:  8
Metab Target Organ Damage. 2025;5:[Accepted].
Author Information
Article Notes
Cite This Article

Abstract

Polycystic ovary syndrome (PCOS) is a complex disorder with a great heterogeneity of signs and symptoms, however, hyperandrogenism is considered a hallmark of PCOS, presented by most affected women. Women with PCOS are at high risk of developing type 2 diabetes mellitus (T2DM), which is associated with insulin resistance (IR) and hyperinsulinemia. In turn, hyperinsulinemia interferes with the androgen production by ovarian cells, and worsens the hyperandrogenism, initiating a feedback cycle. Women with PCOS are also at a greater risk of developing obesity. Indeed, a dysfunctional adipose tissue in obesity contributes to T2DM in PCOS by affecting insulin action and secretion through multiple mechanisms, such as lipotoxicity, inflammation, and adipokine signaling. Therefore, obesity-disrupted adipose tissue can be seen as an important target for T2DM development in women with PCOS. Because adipose tissue can be positively affected by non-pharmacological and easily accessible strategies such as physical exercise, in this review we provide a comprehensive summary of the benefits of physical exercise to improve adipose tissue health and decrease the risk of obesity and T2DM in women with PCOS.

Keywords

Polycystic ovary syndrome, type 2 diabetes mellitus, obesity, adipose tissue, physical exercise

Cite This Article

Santos MP, Azevedo-Martins AK, Rodrigues AO, Aquino NSS, Evangelista FS. Physical exercise for obesity and T2DM mitigation in Polycystic Ovary Syndrome: the role of adipose tissue. Metab Target Organ Damage. 2025;5:[Accept]. http://dx.doi.org/10.20517/mtod.2024.97

Copyright

...
© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Cite This Article 0 clicks
Share This Article
Scan the QR code for reading!
See Updates
Hot Topics
metabolic syndrome | kidney | atherosclerosis | endocrine disorder | NAFLD | diabetes | MAFLD | adipose tissue | obesity | obesity | metabolism | fatty liver | steatosis | fibrosis | cardiovascular | insulin resistance | hypertension | metabolomics | precision medicine | hypertriglyceridemia |
Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/